Cardiopulmonary Exercise Testing and Preoperative Risk Stratification
NCT ID: NCT00737828
Last Updated: 2014-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
228 participants
INTERVENTIONAL
2008-08-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit
NCT07313488
Perioperative Optimization With Enhanced Recovery
NCT04504266
Estimated Oxygen Extraction Versus Dynamic Parameters for Perioperative Hemodynamic Optimization
NCT04053595
The Nociception Level During General Anesthesia
NCT01978379
Deep Breathing Exercise With Incentive Spirometer Started in the Preoperative Period
NCT05428722
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tests used to assess risk of surgery to patients are largely ineffective. Cardiopulmonary exercise tests (CPX) seem to be effective at identifying patients at risk of death or serious illness post surgery. This information has been used in studies to select patients for ICU beds and reduce deaths. The studies so far have limitations in their design and scope which means we can't be certain this approach works in the UK.
We suggest a study to answer this question more conclusively and more specifically in UK patients. We will randomly divide patients between two groups. In the 1st group choice of postoperative care environment is based on best current practice and in the other group we will make these decisions (critical care or ward) based on the results of the CPX.
We hope that the benefits will include less patients becoming seriously ill or dying and shorter stays in hospital after surgery following major operations. We also hope the information will help patients understand the risks of their operation better and therefore make better informed decisions. This may also reduce the overall cost of surgery for hospitals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Control - Standard Perioperative Pathway, clinician decides post-operative care environment (usual care)
Perioperative care pathway guided by CPX results
* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
B
Intervention - Perioperative care pathway guided by CPX Results i.e.anaerobic threshold \& ventilatory equivalents
Perioperative care pathway guided by CPX results
* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Perioperative care pathway guided by CPX results
* AT \> 11ml/min/kg no myocardial ischaemia or Ve/VO2 \<35 - Level 1 Ward Care
* AT \> 11ml/min/kg with myocardial ischaemia or Ve/VO2 \>35 - Level 2/3 (ITU) Critical Care Unit
* AT \<11mls/min/kg - Level 2/3 Critical Care Unit
* AT \<8mls/min/kg - Level 2/3 Critical Care Unit/ consider cancellation or alternative procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Males
3. Females
4. Listed for elective(non-emergency) colorectal surgery
Exclusion Criteria
2. Patient unwilling/unable to consent
3. Adults with learning disabilities or dementia
4. Prisoners
5. Any contraindication to cardiopulmonary exercise testing (as outlined by \*American Association of Anaesthesia:
* Acute MI (3-5 days)
* Unstable angina
* Uncontrolled arrhythmias
* Syncope
* Acute endocarditis
* Acute myocarditis
* Acute pericarditis
* Symptomatic severe aortic stenosis
* Uncontrolled heart failure
* Acute pulmonary embolism or infarction
* Thrombosis of lower extremities
* Dissecting aneurysm
* Uncontrolled asthma
* Pulmonary oedema
* Room air desaturation at rest \<85%
* Respiratory failure
* Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise Mental impairment leading to inability to co-operate
6. Patients already enrolled in an interventional study
7. Previous CPX test result recorded in the medical notes
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Southampton NHS Foundation Trust
OTHER
University College London Hospitals
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mike Grocott
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael PW Grocott
Role: STUDY_DIRECTOR
University College, London
Paula Meale
Role: PRINCIPAL_INVESTIGATOR
University College, London
Michael Mythen
Role: PRINCIPAL_INVESTIGATOR
University College, London
Ayo Oshowo
Role: PRINCIPAL_INVESTIGATOR
Whittington Hospital NHS Trust
Mervyn Singer
Role: PRINCIPAL_INVESTIGATOR
University College, London
Geoff Bellingan
Role: PRINCIPAL_INVESTIGATOR
University College London Hospitals
Kay Mitchell
Role: PRINCIPAL_INVESTIGATOR
University College, London
Hasan Muktar
Role: PRINCIPAL_INVESTIGATOR
The Whittington Hospital Hospital NHS Trust
Alistair Windsor
Role: PRINCIPAL_INVESTIGATOR
University College London Hospitals
Jim Down
Role: PRINCIPAL_INVESTIGATOR
University College London Hospitals
Martin B Kuper
Role: PRINCIPAL_INVESTIGATOR
Whittington Hospital NHS Trust
Denny ZH Levett
Role: PRINCIPAL_INVESTIGATOR
University College, London
Phil Hennis, PhD
Role: PRINCIPAL_INVESTIGATOR
UCL
Alasdair O'Doherty, MSc
Role: PRINCIPAL_INVESTIGATOR
UCL
Alec Engledow
Role: PRINCIPAL_INVESTIGATOR
UCLH
Aundrea Mulreany
Role: PRINCIPAL_INVESTIGATOR
Whittington Hospital
Carolyn Dr Way
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Karen Linford
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Clare Bolger
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Paul Nichols
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Kim Golder
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
John S Knight
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Michael Celinski
Role: PRINCIPAL_INVESTIGATOR
University Hospital Southampton NHS Foundation Trust
Grace Adesina
Role: PRINCIPAL_INVESTIGATOR
University College London Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Whittington Hospital NHS Trust
London, , United Kingdom
University College London Hospitals NHS Foundation Trust
London, , United Kingdom
Southampton University Hospitals NHS Trust
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07/H0716/55
Identifier Type: OTHER
Identifier Source: secondary_id
PB-PG-0906-11426
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
07/0114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.